PRENATAL TREATMENT OF CONGENITAL ADRENAL-HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY

被引:72
作者
PANG, S
POLLACK, MS
MARSHALL, RN
IMMKEN, L
机构
[1] BAYLOR UNIV,HISTOCOMPATIBIL & CLIN IMMUNOL LAB,HOUSTON,TX 77030
[2] METHODIST HOSP,HOUSTON,TX 77030
[3] UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,HOUSTON,TX 77225
关键词
D O I
10.1056/NEJM199001113220207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CONGENITAL adrenal hyperplasia due to 21-hydroxylase deficiency is the most common cause of female pseudohermaphroditism. The severe classic disorder results in excess adrenal secretion of androgen from early fetal life, thereby causing the virilization of the external genitalia of affected female fetuses from the time of sexual differentiation onward. In human fetuses, sexual differentiation is believed to occur between 9 and 13 weeks of gestation.12 We can thus presume that the increased secretion of androgen by the adrenals in fetuses with congenital adrenal hyperplasia begins during or even before this critical period. Congenital adrenal hyperplasia is an HLA-linked autosomal recessive … © 1990, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 41 条
[1]   CORTICOTROPIN-RELEASING FACTOR-LIKE IMMUNOREACTIVITY AND BIOACTIVITY OF HUMAN-FETAL AND ADULT HYPOTHALAMI [J].
ACKLAND, JF ;
RATTER, SJ ;
BOURNE, GL ;
REES, LH .
JOURNAL OF ENDOCRINOLOGY, 1986, 108 (02) :171-180
[2]   METABOLIC CLEARANCE RATE, BLOOD PRODUCTION, INTERCONVERSION AND TRANSPLACENTAL PASSAGE OF CORTISOL AND CORTISONE IN PREGNANCY NEAR TERM [J].
BEITINS, IZ ;
BAYARD, F ;
ANCES, IG ;
KOWARSKI, A ;
MIGEON, CJ .
PEDIATRIC RESEARCH, 1973, 7 (05) :509-519
[3]  
BENIRSCHKE K, 1956, OBSTET GYNECOL, V8, P412
[4]  
BLUMENFELD Z, 1985, 32ND SOC GYN INV ANN, P85
[5]   REGULATION OF THE HYPOTHALAMIC PITUITARY-ADRENAL AXIS IN BIRTH [J].
BROOKS, AN ;
CHALLIS, JRG .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1988, 66 (08) :1106-1112
[6]   HLA TYPING USED WITH CULTURED AMNIOTIC AND CHORIONIC VILLUS CELLS FOR EARLY PRENATAL-DIAGNOSIS OR PARENTAGE TESTING WITHOUT ONE PARENTS AVAILABILITY [J].
CALLAWAY, C ;
FALCON, C ;
GRANT, G ;
MAURER, DH ;
AUERBACH, AD ;
ROSENWAKS, Z ;
POLLACK, MS .
HUMAN IMMUNOLOGY, 1986, 16 (02) :200-204
[7]   PRENATAL THERAPY IN CONGENITAL ADRENAL-HYPERPLASIA - ATTEMPTED PREVENTION OF ABNORMAL EXTERNAL GENITAL MASCULINIZATION BY PHARMACOLOGICAL SUPPRESSION OF THE FETAL ADRENAL-GLAND INUTERO [J].
CHROUSOS, GP ;
EVANS, MI ;
LORIAUX, DL ;
MCCLUSKEY, J ;
FLETCHER, JC ;
SCHULMAN, JD .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 458 :156-164
[8]   PRENATAL-DIAGNOSIS OF CONGENITAL ADRENAL-HYPERPLASIA (21-OH DEFICIENCY TYPE) BY HLA TYPING [J].
COUILLIN, P ;
BOUE, J ;
NICOLAS, H ;
CHERUY, C ;
BOUE, A .
PRENATAL DIAGNOSIS, 1981, 1 (01) :25-33
[9]   PRENATAL TREATMENT OF CONGENITAL ADRENAL-HYPERPLASIA RESULTING FROM 21-HYDROXYLASE DEFICIENCY [J].
DAVID, M ;
FOREST, MG .
JOURNAL OF PEDIATRICS, 1984, 105 (05) :799-803
[10]  
DORR HG, 1988, 70TH P ANN M END SOC, P21